Journal
RNA BIOLOGY
Volume 12, Issue 5, Pages 479-485Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15476286.2015.1020272
Keywords
regulated splicing; genomic binding profile; definition of functional 3 '; U2AF heterodimer; splice sites; cooperation and competition in RNA binding; disease mechanism
Categories
Funding
- NHGRI NIH HHS [R01 HG004659, HG004659] Funding Source: Medline
- NIDDK NIH HHS [DK098808] Funding Source: Medline
- NIGMS NIH HHS [R01 GM049369, GM049369] Funding Source: Medline
Ask authors/readers for more resources
The U2AF heterodimer is generally accepted to play a vital role in defining functional 3 ' splice sites in pre-mRNA splicing. Given prevalent mutations in U2AF, particularly in the U2AF1 gene (which encodes for the U2AF35 subunit) in blood disorders and other human cancers, there are renewed interests in these classic splicing factors to further understand their regulatory functions in RNA metabolism in both physiological and disease settings. We recently reported that U2AF has a maximal capacity to directly bind similar to 88% of functional 3 ' splice sites in the human genome and that numerous U2AF binding events also occur in various exonic and intronic locations, thus providing additional mechanisms for the regulation of alternative splicing besides their traditional role in titrating weak splice sites in the cell. These findings, coupled with the existence of multiple related proteins to both U2AF65 and U2AF35, beg a series of questions on the universal role of U2AF in functional 3 ' splice site definition, their binding specificities in vivo, potential mechanisms to bypass their requirement for certain intron removal events, contribution of splicing-independent functions of U2AF to important cellular functions, and the mechanism for U2AF mutations to invoke specific diseases in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available